Strategic Partnership Pharmex recently entered a five-year contract manufacturing agreement with Cana Laboratories (Cosmos Health group), signaling strong potential for expanded B2B manufacturing partnerships and co-development opportunities in Rx, OTC products and medical devices across MEA and LATAM.

Global Footprint With headquarters in Switzerland and an operational base in Madrid, Pharmex presents a global supply capability and regional reach that can support multinational customers seeking consistent quality and scale in regulated markets.

Growth Signals Recent collaboration announcements and a revenue range of 1–10 million USD indicate a growth-oriented, cost-efficient manufacturer eager to scale through contract manufacturing, enabling targeted outreach to mid-market pharma companies seeking reliable production partners.

Diverse Portfolio Focus on Rx, OTC and Medical Devices suggests cross-sell opportunities across multiple product categories for customers looking to consolidate manufacturing partners and streamline regulatory filings.

Target Regions Pharmex emphasizes access to health in MEA and LATAM, presenting compelling entry points for regional distributors, generic manufacturers, and specialty pharma players aiming to expand in these markets through local production and compliance capabilities.